MOTS-c administration improves insulin sensitivity in skeletal muscle and glucose homeostasis by inducing an exercise-mimicking effect [9], indicating its benefits for various metabolic diseases such as obesity and type 2 diabetes (T2D). This evidence concerns the gene INS and type 2 diabetes mellitus.